Z7_K8M0I8402PTU806OF5GPF03SV3

NAHDI

17 March, 2024 17:01

Nahdi Medical Co. announces its Annual Financial results for the period ending on 2023-12-31

Element ListCurrent YearPrevious Year%Change
Sales/Revenue 8,713.78,616.21.13
Gross Profit (Loss) 3,522.23,545.4-0.65
Operational Profit (Loss) 9611,002.6-4.15
Net profit (Loss) 892.6887.80.54
Total Comprehensive Income 934.4940.1-0.61
Total Share Holders Equity (After Deducting the Minority Equity) 2,462.82,243.49.78
Profit (Loss) per Share 6.876.83
All figures are in (Millions) Saudi Arabia, Riyals


Element ListAmountPercentage of the capital (%)
Profit (Losses) Resulting From The Change In Investment Propertie’s Fair Value --
All figures are in (Millions) Saudi Arabia, Riyals


Element ListExplanation
The reason of the increase (decrease) in the sales/ revenues during the current year compared to the last year Revenue: In 2023, Nahdi posted revenue of SAR 8,713.7 million, an increase of 1.1% or SAR 97.5 million, as compared to SAR 8,616.2 million in FY 2022. The increase was due to growth in the Pharma segment as well as healthcare and UAE business. This growth was partially offset by a decline in certain divisions within the Front Shop segment. It is worth noting that the company's overall revenue grew by 3.6% in Q4 2023 compared to the same period last year. The uptick in revenue was driven mainly by investments in promotions (please refer to the attached press release for detailed analysis).
The reason of the increase (decrease) in the net profit during the current year compared to the last year is Net Profit: The company’s net profit was SAR 892.6 million, an increase of 0.5% or SAR 4.8 million, as compared to SAR 887.8 million in FY 2022, due to the following reasons: - Gross Profit declined 0.7% versus the same period last year, primarily due to the investment in sales promotions to support Front Shop sales. Gross margin was 40.4% of revenue in FY 2023 as compared to 41.1% in the same period last year. - Operating Profit decreased by 4.2% mainly due to lower gross profit. The company’s operating expenses remained flat at 29.7% of revenue despite the investments in different strategic initiatives such as healthcare, ecommerce and the UAE operations. The savings generated from our established efficiencies programs, helped the company to fund most of these investments. - The decline in operating profit was fully offset by the income generated from Islamic Murabaha time deposits which resulted in a net profit of SAR 892.6 million. Net profit margin remained almost flat at 10.2% versus last year.
Statement of the type of external auditor's report Unmodified opinion
Comment mentioned in the external auditor’s report, mentioned in any of the following paragraphs (other matter, conservation, notice, disclaimer of opinion, or adverse opinion) None
Reclassification of Comparison Items Certain comparative information has been reclassified to align with the current presentation for the period ending 31 December 2023.
Additional Information Other Comprehensive Income slightly decreased mainly due to the global change in interest rates, impacting the actuarial estimate for the end-of-service indemnity.
Attached Documents  

Other Announcements

RAWASI
2025-05-18

Rawasi Albina Investment Co. Announces an update on to establish a limited liability company

Read More
THARWAH
2025-05-18

Altharwah Albashariyyah Co. Announces the Latest Developments Regarding the Signing of the Binding and Conditional Acquisition and Subscription Agreement to Acquire 100% of the Share Capital of Amjad Watan for Exhibitions and Conferences Management (a One-Person Company)

Read More
THARWAH
2025-05-18

Altharwah Albashariyyah Co. Announces the Board of Directors’ Recommendation to Buy-back its Shares

Read More
Z7_K8M0I84021EV8060AAR40C00B7